Efficacy of dermal redensification in chronoaged face: Quantitative volumetric assessment.

Background: Mesotherapy for chronoaged skin shows heterogeneous results.

Objectives: The aim of the study was to assess the efficacy of dermal redensification on the face and neck.

Methods: Patients with mild-moderate-severe chronoaging of face and neck were included and, every 14 days, treated with four sessions of dermal redensification, consisting of 1 mL of hyaluronic acid (15 mg/mL) plus a dermo-restructuring complex.

Neuropsychological alterations in hepatitis C infection: the role of inflammation.

About 50% of patients with hepatitis C virus (HCV) infection complain of neuropsychiatric symptoms, "brain fog", weakness, fatigue, and exhibit some degree of quality of life impairment, irrespective of the severity of liver disease. Since the first observation of HCV-related cognitive deficits, 10 studies have been published that have evaluated neuropsychiatric performance in patients with HCV infection and different degrees of hepatic impairment. Unfortunately, these have often included patients with cirrhosis, patients who had acquired the infection through previous intravenous drug misuse, who had a history of relatively recent treatment with interferon, or were on psychoactive medication.

Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.

Background: Hepatitis C virus (HCV) reinfection after liver transplantation is a virtually constant finding and leads to chronic hepatitis and cirrhosis in variable proportions. This study aimed to assess the safety and efficacy of alpha-interferon (IFN) plus ribavirin for recurrent HCV following liver transplantation.

Patients And Methods: Thirty of 55 patients (54.